DYNC2H1

Overview

DYNC2H1 is a gene that encodes the cytoplasmic dynein 2 heavy chain 1 protein, which is a crucial component of the dynein motor complex. This complex is involved in retrograde intraflagellar transport (IFT) within cilia, a process essential for the proper functioning and maintenance of cilia. Mutations in the DYNC2H1 gene have been associated with several ciliopathies, including Jeune syndrome and short-rib thoracic dysplasia.

Structure

The DYNC2H1 gene is located on chromosome 11q22.3 and spans approximately 1.5 Mb of genomic DNA. It consists of 90 exons and encodes a protein of 4,409 amino acids. The protein is a part of the dynein motor complex, which is a large multi-subunit complex that includes light, intermediate, and heavy chains. The heavy chain encoded by DYNC2H1 is responsible for ATPase activity and motor function.

Function

The primary function of the DYNC2H1 protein is to facilitate retrograde IFT, which is the transport of molecular cargo from the tip of the cilium back to the base. This process is vital for the recycling of ciliary components and the maintenance of ciliary structure and function. The dynein motor complex moves along microtubules, utilizing ATP hydrolysis to generate mechanical force.

Clinical Significance

Mutations in the DYNC2H1 gene can lead to a spectrum of disorders known as ciliopathies. These include:

• Jeune syndrome: A skeletal dysplasia characterized by a narrow thorax, short ribs, and limb shortening. It can lead to respiratory insufficiency and other complications.
• Short-rib thoracic dysplasia: A group of disorders with similar skeletal abnormalities as Jeune syndrome, often with additional features such as polydactyly and renal anomalies.

Patients with DYNC2H1 mutations may present with a range of phenotypes, from mild to severe, depending on the nature and location of the mutation.

Research and Future Directions

Ongoing research aims to better understand the molecular mechanisms by which DYNC2H1 mutations lead to ciliopathies. There is also interest in developing therapeutic strategies to address the underlying defects in ciliary function. Gene therapy and small molecule modulators of ciliary transport are potential areas of exploration.

Also see

• Cilia
• Intraflagellar transport
• Ciliopathy
• Dynein
• Jeune syndrome
• Short-rib thoracic dysplasia